Overview

The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes

Status:
Unknown status
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This prospective clinical trial evaluates the effect of a two dose GnRH agonist administered in the luteal phase on the outcome of ART cycles stimulated with the long GnRH agonist and GnRH antagonist protocol.
Phase:
N/A
Details
Lead Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital
Treatments:
Deslorelin
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Leuprolide
Polyestradiol phosphate
Progesterone
Triptorelin Pamoate